Loading...
In patients with asthma, lower serum levels of 25-hydroxyvitamin D have been associated with more-frequent exacerbations, airway hyper-responsiveness, and decreased lung function. Low vitamin D levels theoretically could exacerbate pro-inflammatory states and reduce corticosteroid responsiveness. To determine whether vitamin D supplementation improves responsiveness to corticosteroid therapy, investigators randomized 408 adults (mean age, 40) with asthma and 25-hydroxyvitamin D levels <30 ng/mL (mean, 18.8 ng/mL) to high-dose oral vitamin D3 supplementation (initial dose of 100,000 IU followed by 4000 IU daily) or placebo for 28 weeks. All participants received the inhaled corticosteroid ciclesonide (320 μg daily). During the study period, …